CG
TDOC icon

Cutler Group’s Teladoc Health TDOC Stock Holding History

Cutler Group’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-77,000
Closed -$42K – 3555
2023
Q4 		$42K Buy
77,000
+3,300
+4% +$60.9K ﹤0.01% 1548
2023
Q3 		$19K Sell
73,700
-24,300
-25% -$567K ﹤0.01% 2079
2023
Q2 		$37K Buy
98,000
+53,100
+118% +$1.34M 0.01% 1488
2023
Q1 		$59K Sell
44,900
-80,300
-64% -$2.15M 0.01% 1247
2022
Q4 		$36K Buy
125,200
+8,800
+8% +$237K ﹤0.01% 1809
2022
Q3 		$86K Buy
116,400
+39,300
+51% +$1.38M 0.01% 1504
2022
Q2 		$113K Sell
77,100
-65,300
-46% -$2.77M 0.01% 1361
2022
Q1 		$298K Sell
142,400
-28,500
-17% -$2.05M 0.02% 948
2021
Q4 		$446K Buy
170,900
+115,300
+207% +$13.8M 0.02% 810
2021
Q3 		$179K Sell
55,600
-43,700
-44% -$6.36M 0.01% 1445
2021
Q2 		$1.27M Buy
99,300
+57,000
+135% +$9.24M 0.06% 366
2021
Q1 		$366K Sell
42,300
-12,900
-23% -$2.99M 0.02% 897
2020
Q4 		$1.1M Buy
55,200
+33,300
+152% +$6.77M 0.05% 363
2020
Q3 		$797K Buy
21,900
+3,200
+17% +$678K 0.05% 387
2020
Q2 		$667K Sell
18,700
-15,400
-45% -$2.7M 0.04% 406
2020
Q1 		$695K Buy
34,100
+17,400
+104% +$2.02M 0.04% 449
2019
Q4 		$49K Sell
16,700
-9,400
-36% -$715K ﹤0.01% 1647
2019
Q3 		$52K Buy
26,100
+10,400
+66% +$684K ﹤0.01% 1517
2019
Q2 		$39K Buy
15,700
+7,800
+99% +$455K ﹤0.01% 1738
2019
Q1 		$6K Buy
7,900
+5,800
+276% +$354K ﹤0.01% 2833
2018
Q4 		$5K Sell
2,100
-2,200
-51% -$135K ﹤0.01% 2948
2018
Q3 		$59K Sell
4,300
-3,100
-42% -$221K ﹤0.01% 1510
2018
Q2 		$191K Buy
7,400
+800
+12% +$39.1K 0.02% 799
2018
Q1 		$73K Buy
6,600
+6,000
+1,000% +$226K 0.01% 1412
2017
Q4 		$1K Sell
600
-24,400
-98% -$810K ﹤0.01% 4573
2017
Q3 		$266K Sell
25,000
-3,700
-13% -$121K 0.01% 985
2017
Q2 		$357K Sell
28,700
-2,200
-7% -$64.1K 0.01% 894
2017
Q1 		$136K Buy
+30,900
New +$643K 0.01% 1477
2016
Q4 		– Sell
-1,000
Closed -$1K – 7286
2016
Q3 		$1K Buy
+1,000
New +$17.5K ﹤0.01% 6284

Other funds holding TDOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Cutler Group's TDOC Position: Q1 2024 in Review

Cutler Group reduced its Teladoc Health (TDOC) stake by 80% in Q1 2024, selling an estimated $335K and leaving 4,646 shares worth $70K. The position accounts for 0.02% of the portfolio, ranked #552.

Cutler Group first reported a position in TDOC in Q1 2016 and has held it in 31 quarters since. The position peaked at $9.47M in Q1 2021. 426 funds tracked by Wall St. Rank hold TDOC as of Q1 2024.

  • Cutler Group held 4,646 shares of Teladoc Health worth $70K as of Q1 2024.
  • Cutler Group sold 18,444 Teladoc Health shares in Q1 2024, an estimated $335K.
  • Teladoc Health made up 0.02% of Cutler Group's portfolio in Q1 2024, its #552 holding.
  • Cutler Group first reported a position in Teladoc Health in Q1 2016 and has held it in 31 quarters since.
  • Cutler Group's Teladoc Health position peaked at $9.47M in Q1 2021.
  • 426 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.